Careers
News & Insights
Contact
Search

Strategy
Science
- Our LNP Technology
- Our Clinical Applications
Company

Home
News
Article

July 3, 2025

Acuitas Therapeutics collaborates on mRNA-LNP prime editing study for genetic liver disease

Strategy

The Acuitas Advantage
Our Partnerships
Our Capabilities

Science

Our LNP Technology
Our Clinical Applications

Company

About Us
Our Team
Our Community Impact
Search

Connect

Careers
News & Insights
Contact
Search

Privacy Policy
Terms of Service
Cookie Policy
Sitemap

© 2026 Acuitas. All rights reserved.